ARMOCIBART
UNII YDG29RXC35

Substance Identification & Data

This profile provides standardized clinical and technical data for Armocibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YDG29RXC35.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2857858-84-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YDG29RXC35

CAS Registry Number

2857858-84-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ARMOCIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211828

National Cancer Institute reference terminology for clinical and research data.

INN ID

13116

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Armocibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ARMOCIBART

Common Names & Synonyms

ARMOCIBART [INN]

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TFPI (TISSUE FACTOR PATHWAY INHIBITOR, EXTRINSIC PATHWAY INHIBITOR, EPI, LIPOPROTEIN ASSOCIATED COAGULATION INHIBITOR, LACI))

External Clinical & Regulatory Resources

Previous UNIIYDF52K5SDR

Next UNIIYDG758X99Q